Vaccine stocks decline after Trump nominates Robert Kennedy Jr. as health official
ft.com —
Shares of vaccine manufacturers fell sharply on Friday after Donald Trump nominated Robert F. Kennedy Jr. as the top U.S. health official. Moderna dropped 6%, while Pfizer and major vaccine makers GSK and Sanofi also saw significant declines. Kennedy, a known vaccine skeptic, would oversee key health agencies if confirmed. His nomination raised concerns about potential changes in vaccine policy and regulation, impacting investor confidence in the pharmaceutical sector. Analysts noted that Kennedy's views could worsen the already challenging outlook for vaccine makers. Stocks of companies like Bavarian Nordic also plummeted, despite the firm maintaining its financial guidance.